Share this page
United Kingdom08/02/2023
EAHAD 2023
Octapharma Symposium
Concomitant use of factor VIII and emicizumab in haemophilia A
Patient cases and clinical trials
Wednesday, 8 February 2023
17:15-18:30 GMT
Exchange Auditorium | Manchester, UK
Join our speakers for an interactive session as they follow three different patient cases. Together with you, they will explore the clinical and treatment journey of each patient from both the clinician and patient perspective.
Symposium agenda
Agenda | Speaker |
|---|---|
Welcome and introduction | Chair: Guy Young, US |
Choosing the right treatment strategy for previously untreated patients | Guy Young, US |
A new frontier in inhibitor management*: an update from the MOTIVATE study | Carmen Escuriola Ettingshausen, DE |
Controlling bleeding during surgery: clarifying the role of VIII | Steve Austin, UK |
Q&A and concluding remarks | Speakers and audience |
* as during the course of bleeding management
Meet the speakers
Guy Young
Children’s Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, US
Carmen Escuriola Ettingshausen
Haemophilia Centre Rhein Main (HZRM) Mörfelden-Walldorf, DE
Steve Austin
St George's University Hospitals NHS Foundation Trust Guys and St Thomas’ NHS Foundation Trust, London, UK